Agenus Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Agenus Stock Summary

Agenus competes with Marker Therapeutics, Edgewise Therapeutics, Adaptimmune Therapeutics, Mereo BioPharma, and Pieris Pharmaceuticals. Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts. Agenus operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 441 people.

Agenus Key Financial Ratios

Agenus Key Balance Sheet Accounts

Agenus Key Income Statement Accounts

Agenus Key Cash Accounts

Agenus Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Agenus's current stock value. Our valuation model uses many indicators to compare Agenus value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Agenus competition to find correlations between indicators driving Agenus's intrinsic value. More Info.Agenus Inc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Agenus' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Agenus' earnings, one of the primary drivers of an investment's value.

Agenus' Earnings Breakdown by Geography

Agenus Inc Systematic Risk

Today, most investors in Agenus Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Agenus' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Agenus growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Agenus help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Agenus Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Agenus Inc based on widely used predictive technical indicators. In general, we focus on analyzing Agenus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Agenus's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agenus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Agenus Inc is measured differently than its book value, which is the value of Agenus that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agenus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.